FSD Pharma has partnered with Solarvest BioEnergy on a collaborate research and development agreement to "develop algae-based, pharma-grade cannabinoids." It's said the process could significantly reduce cannabinoid production time. Solarvest is a technology company that developed an algal-based flexible production platform...
It has been announced that HelloMD will provide patients in Canada with "convenient access to practitioner-led advice about medical cannabis" through a new relationship with Shoppers Drug Mart's online medical cannabis platform. HelloMD is the first teleheath provider to be selected by Shoppers.
Canadian cannabis company Tetra Bio-Pharma has announced it is collaborating with Ovensa in the hopes of finding a new treatment for brain cancer. The research team will evaluate TRIOZANTM, a proprietary nanomedicine platform for targeted delivery of cannabinoids to brain tumor cells.
New study led by NEEKA Health Canada will test if CBD-based therapies can reduce the severity of post-concussion brain disorders in former NHL players A study exploring cannabinoids and concussions is set to begin this summer, in a partnership between the NHL...
Resolve Digital has announced the first of its family of smart vaporizers has been approved by Health Canada for a Medical Device License (MDL) for cannabis use. Called the "Resolve MD," it's said to be the first cannabis-related medical device license issued under...
This latest "Sessions" podcast from The Her(b) Life includes interviews with Grow Tech Labs CEO Barinder Rasode and CannaReps CEO Julie Domingo. It's a discussion about what is needed to create a better future for new and old business in the developing cannabis...
Roughly 25 per cent of teenagers in B.C. have tried marijuana, according to a recently released study. The “2018 BC Adolescent Health Survey” was released in March by the McCreary Centre Society. It’s a survey of more than 38,000 students in Grades 7 to...
By NICHE Canada There’s no doubt that cannabis edibles will have a considerable impact on the Canadian marketplace, both in terms of regulatory complexity and consumer demand. According to Deloitte, Canadians are expected to spend as much as $7 billion...
The Multiple Sclerosis Society of Canada has announced a partnership with the Canadian Institutes of Health Research (CIHR) to provide $1.5 million in funding for cannabis and MS research. According to a release, the funding will go towards research into the use of cannabis...
The upcoming cannabis forum in Toronto will explore a plethora of topics, including mental health, pediatrics and opioid management Cannabis conference O'Cannabiz has announced it will play host to a "Cannabis Meets Healthcare" forum specifically for wellness and medical professionals, including (but...